LCMT1
Leucine carboxyl methyltransferase 1
Also known as: CGI-68, LCMT1_HUMAN, PPMT1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UIC8
- Gene
- LCMT1
- Ensembl
- ENSG00000205629
- Chromosome
- 16
- Canonical length
- 334 aa
- Protein class
- Enzymes, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
LCMT1 catalyzes the methylation of the carboxyl group of the C-terminal leucine residue (leu309) of the catalytic subunit of protein phosphatase-2A (PPP2CA; MIM 176915) (De Baere et al., 1999 [PubMed 10600115]).[supplied by OMIM, Mar 2008]
Canonical amino-acid sequenceUniProt
334 residues, UniProt reviewed canonical sequence.
>Q9UIC8|LCMT1
1 MATRQRESSI TSCCSTSSCD ADDEGVRGTC EDASLCKRFA VSIGYWHDPY IQHFVRLSKE
61 RKAPEINRGY FARVHGVSQL IKAFLRKTEC HCQIVNLGAG MDTTFWRLKD EDLLPSKYFE
121 VDFPMIVTRK LHSIKCKPPL SSPILELHSE DTLQMDGHIL DSKRYAVIGA DLRDLSELEE
181 KLKKCNMNTQ LPTLLIAECV LVYMTPEQSA NLLKWAANSF ERAMFINYEQ VNMGDRFGQI
241 MIENLRRRQC DLAGVETCKS LESQKERLLS NGWETASAVD MMELYNRLPR AEVSRIESLE
301 FLDEMELLEQ LMRHYCLCWA TKGGNELGLK EITYLocalizationUniProt · AlphaFold · HPA
Whether an antibody against LCMT1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.25
- Highest tissue expression
- 51 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 51 nTPM
- cerebral cortex: 48 nTPM
- basal ganglia: 46 nTPM
- choroid plexus: 46 nTPM
- pancreas: 45 nTPM
- hypothalamus: 42 nTPM
Single-cell type
- oocytes: 461 nCPM
- cytotrophoblasts: 248 nCPM
- syncytiotrophoblasts: 206 nCPM
- late spermatids: 198 nCPM
- esophageal apical cells: 168 nCPM
- decidual stromal cells: 132 nCPM
Immune cell
- T-reg: 83 nTPM
- memory CD4 T-cell: 48 nTPM
- eosinophil: 46 nTPM
- MAIT T-cell: 43 nTPM
- naive CD4 T-cell: 43 nTPM
- memory B-cell: 42 nTPM
Brain region
- cerebral cortex: 42 nTPM
- hypothalamus: 38 nTPM
- basal ganglia: 38 nTPM
- pons: 37 nTPM
- white matter: 37 nTPM
- cerebellum: 34 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.87
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.34
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- C-terminal protein methylation
- G2/M transition of mitotic cell cycle
- negative regulation of protein-containing complex assembly
- protein methylation
- protein modification process
- regulation of apoptotic process
- regulation of glucose metabolic process
- regulation of mitotic cell cycle spindle assembly checkpoint
Molecular functions
- protein C-terminal carboxyl O-methyltransferase activity
- S-adenosylmethionine-dependent methyltransferase activity
- protein C-terminal leucine carboxyl O-methyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Methyltransferase Ppm1/Ppm2/Tcmp
- S-adenosyl-L-methionine-dependent methyltransferase superfamily
- Leucine carboxyl methyltransferase
- Leucine carboxyl methyltransferase 1
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of LCMT1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads LCMT1 as an antibody target. Whether an autoantibody or antibody against LCMT1 could matter depends on whether native LCMT1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
LCMT1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label LCMT1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...